The Association of the British Pharmaceutical Industry (ABPI) is warning that the core ambition of the government’s new life sciences strategy will not be realised unless it makes a real commitment to invest more in new medicines. In late June, the government published a new Industrial Strategy, which includes five out of eight specific plans for…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
